{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T21:04:44Z","timestamp":1790283884967,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG078335"],"award-info":[{"award-number":["RF1AG078335"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG078335"],"award-info":[{"award-number":["RF1AG078335"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["slas-discovery.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["SLAS Discovery"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.slasd.2025.100260","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:58:55Z","timestamp":1754927935000},"page":"100260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A high-throughput approach to evaluating NCp7 RNA binding activity for HIV-1 drug discovery"],"prefix":"10.1016","volume":"35","author":[{"given":"Joanna K.","family":"Winstone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikki","family":"Uhrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8459-6443","authenticated-orcid":false,"given":"Thibault","family":"Alle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian C.","family":"Kraemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Supplement 2","key":"10.1016\/j.slasd.2025.100260_bib0001","doi-asserted-by":"crossref","DOI":"10.1097\/QAD.0000000000002983","article-title":"The Joint United Nations Programme on HIV\/AIDS 95\u201395\u201395 targets: worldwide clinical and cost benefits of generic manufacture","volume":"35","author":"Heath","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.slasd.2025.100260_bib0002","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.coviro.2016.03.004","article-title":"Current status and prospects of HIV treatment","volume":"18","author":"Cihlar","year":"2016","journal-title":"Curr Opin Virol"},{"issue":"9734","key":"10.1016\/j.slasd.2025.100260_bib0003","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(10)60676-9","article-title":"Antiretroviral therapy and management of HIV infection","volume":"376","author":"Volberding","year":"2010","journal-title":"Lancet"},{"issue":"9635","key":"10.1016\/j.slasd.2025.100260_bib0004","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","article-title":"Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies","volume":"372","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.slasd.2025.100260_bib0005","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/597093","article-title":"Incomplete peripheral CD4+ cell count restoration in HIV-infected patients receiving long-term antiretroviral treatment","volume":"48","author":"Kelley","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.slasd.2025.100260_bib0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0968-4328(98)00002-X","article-title":"The life-cycle of human immunodeficiency virus type 1","volume":"29","author":"Goto","year":"1998","journal-title":"Micron"},{"issue":"4","key":"10.1016\/j.slasd.2025.100260_bib0007","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/nrmicro2747","article-title":"The structural biology of HIV-1: mechanistic and therapeutic insights","volume":"10","author":"Engelman","year":"2012","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.slasd.2025.100260_bib0008","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1093\/nar\/28.3.663","article-title":"SURVEY AND SUMMARY A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter","volume":"28","author":"Pereira","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"10.1016\/j.slasd.2025.100260_bib0009","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.drudis.2018.01.022","article-title":"NCp7: targeting a multitask protein for next-generation anti-HIV drug development part 2. Noncovalent inhibitors and nucleic acid binders","volume":"23","author":"Iraci","year":"2018","journal-title":"Drug Discov Today"},{"issue":"2","key":"10.1016\/j.slasd.2025.100260_bib0010","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.drudis.2017.10.017","article-title":"NCp7: targeting a multitasking protein for next-generation anti-HIV drug development part 1: covalent inhibitors","volume":"23","author":"Sancineto","year":"2018","journal-title":"Drug Discov Today"},{"issue":"3","key":"10.1016\/j.slasd.2025.100260_bib0011","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0022-2836(03)00472-8","article-title":"Analysis of NCp7-dependent activation of HIV-1 cDNA integration and its conservation among retroviral nucleocapsid proteins","volume":"329","author":"Poljak","year":"2003","journal-title":"J Mol Biol"},{"issue":"6","key":"10.1016\/j.slasd.2025.100260_bib0012","doi-asserted-by":"crossref","first-page":"744","DOI":"10.4161\/rna.7.6.14065","article-title":"Properties and functions of the nucleocapsid protein in virus assembly","volume":"7","author":"Muriaux","year":"2010","journal-title":"RNA Biol"},{"issue":"5","key":"10.1016\/j.slasd.2025.100260_bib0013","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1042\/BST20160101-T","article-title":"The multiple roles of the nucleocapsid in retroviral RNA conversion into proviral DNA by reverse transcriptase","volume":"44","author":"Darlix","year":"2016","journal-title":"Biochem Soc Trans"},{"issue":"2","key":"10.1016\/j.slasd.2025.100260_bib0014","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0116921","article-title":"Investigating the cellular distribution and interactions of HIV-1 nucleocapsid protein by quantitative fluorescence microscopy","volume":"10","author":"Anton","year":"2015","journal-title":"PloS one"},{"issue":"3","key":"10.1016\/j.slasd.2025.100260_bib0015","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.chom.2016.02.004","article-title":"HIV-1 nucleocapsid mimics the membrane adaptor syntenin PDZ to gain access to ESCRTs and promote virus budding","volume":"19","author":"Sette","year":"2016","journal-title":"Cell host microbe"},{"issue":"10","key":"10.1016\/j.slasd.2025.100260_bib0016","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1128\/JVI.77.10.5547-5556.2003","article-title":"Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant","volume":"77","author":"Ott","year":"2003","journal-title":"J virol"},{"key":"10.1016\/j.slasd.2025.100260_bib0017","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/aid.1987.3.253","volume":"3","author":"DiMarzo-Veronese","year":"1987","journal-title":"AIDS Res Hum Retrovir"},{"issue":"8","key":"10.1016\/j.slasd.2025.100260_bib0018","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1002\/j.1460-2075.1992.tb05377.x","article-title":"Determination of the structure of the nucleocapsid protein NCp7 from the human immunodeficiency virus type 1 by 1H NMR","volume":"11","author":"Morellet","year":"1992","journal-title":"Embo j"},{"issue":"5","key":"10.1016\/j.slasd.2025.100260_bib0019","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jmb.2006.08.070","article-title":"Rapid kinetics of protein\u2013nucleic acid interaction is a major component of HIV-1 nucleocapsid protein\u2019s nucleic acid chaperone function","volume":"363","author":"Cruceanu","year":"2006","journal-title":"J mol biol"},{"issue":"12","key":"10.1016\/j.slasd.2025.100260_bib0020","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1021\/acsinfecdis.9b00272","article-title":"HIV-1 Nucleocapsid Protein Unfolds Stable RNA G-Quadruplexes in the Viral Genome and Is Inhibited by G-Quadruplex Ligands","volume":"5","author":"Butovskaya","year":"2019","journal-title":"ACS Infect Dis"},{"issue":"12","key":"10.1016\/j.slasd.2025.100260_bib0021","doi-asserted-by":"crossref","first-page":"3248","DOI":"10.1093\/jac\/dku280","article-title":"Anti-HIV-1 activity of the G-quadruplex ligand BRACO-19","volume":"69","author":"Perrone","year":"2014","journal-title":"J Antimicrob Chemother"},{"issue":"16","key":"10.1016\/j.slasd.2025.100260_bib0022","doi-asserted-by":"crossref","first-page":"6521","DOI":"10.1021\/jm400914r","article-title":"A dynamic G-quadruplex region regulates the HIV-1 long terminal repeat promoter","volume":"56","author":"Perrone","year":"2013","journal-title":"J Med Chem"},{"issue":"19","key":"10.1016\/j.slasd.2025.100260_bib0023","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1093\/nar\/gkg716","article-title":"G-quartets direct assembly of HIV-1 nucleocapsid protein along single-stranded DNA","volume":"31","author":"Lyonnais","year":"2003","journal-title":"Nucleic Acids Res"},{"issue":"14","key":"10.1016\/j.slasd.2025.100260_bib0024","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1093\/nar\/gki741","article-title":"Unfolding of DNA quadruplexes induced by HIV-1 nucleocapsid protein","volume":"33","author":"Kankia","year":"2005","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"10.1016\/j.slasd.2025.100260_bib0025","doi-asserted-by":"crossref","first-page":"an8","DOI":"10.1038\/nmeth.f.230","article-title":"AlphaLISA immunoassays: the no-wash alternative to ELISAs for research and drug discovery","volume":"5","author":"Beaudet","year":"2008","journal-title":"Nat Methods"},{"issue":"3","key":"10.1016\/j.slasd.2025.100260_bib0026","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/2472555220958387","article-title":"AlphaScreen Identifies MSUT2 Inhibitors for Tauopathy-Targeting Therapeutic Discovery","volume":"26","author":"Baker","year":"2021","journal-title":"SLAS Discov"},{"issue":"9","key":"10.1016\/j.slasd.2025.100260_bib0027","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/1087057110382778","article-title":"Development of a Novel Nonradiometric Assay for Nucleic Acid Binding to TDP-43 Suitable for High-Throughput Screening Using AlphaScreen\u00ae Technology","volume":"15","author":"Cassel","year":"2010","journal-title":"J Biomol Screen"},{"issue":"7","key":"10.1016\/j.slasd.2025.100260_bib0028","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/acsinfecdis.9b00011","article-title":"Stable and Conserved G-Quadruplexes in the Long Terminal Repeat Promoter of Retroviruses","volume":"5","author":"Ruggiero","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.slasd.2025.100260_bib0029","series-title":"Chapter Five - Danazol, in Profiles of Drug Substances, Excipients and Related Methodology","first-page":"149","author":"Al-Badr","year":"2022"},{"issue":"2","key":"10.1016\/j.slasd.2025.100260_bib0030","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1872-034X.2007.00297.x","article-title":"Ursodeoxycholic acid: Mechanism of action and novel clinical applications","volume":"38","author":"Ikegami","year":"2008","journal-title":"Hepatol Res"},{"issue":"8","key":"10.1016\/j.slasd.2025.100260_bib0031","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1542\/pir.25-8-284","article-title":"Chloramphenicol: A Review","volume":"25","author":"Balbi","year":"2004","journal-title":"Pediatr Rev"},{"issue":"6","key":"10.1016\/j.slasd.2025.100260_bib0032","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.jmb.2018.01.016","article-title":"Binding and Action of Amino Acid Analogs of Chloramphenicol upon the Bacterial Ribosome","volume":"430","author":"Tereshchenkov","year":"2018","journal-title":"J Mol Biol"},{"issue":"2","key":"10.1016\/j.slasd.2025.100260_bib0033","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004630-199303000-00006","article-title":"Five Percent Mafenide Acetate Solution in the Treatment of Thermal Injuries","volume":"14","author":"Kucan","year":"1993","journal-title":"J Burn Care Rehabil"},{"key":"10.1016\/j.slasd.2025.100260_bib0034","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.taap.2019.03.016","article-title":"Pharmacology, toxicology and clinical safety of glycopyrrolate","volume":"370","author":"Chabicovsky","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"10.1016\/j.slasd.2025.100260_bib0035","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2125.1983.tb01552.x","article-title":"Effects of terbutaline sulphate aerosol on bronchodilator response and lung mucociliary clearance in patients with mild stable asthma","volume":"15","author":"Bateman","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.slasd.2025.100260_bib0036","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0007-0971(88)90064-2","article-title":"Terbutaline and diaphragm function in chronic obstructive pulmonary disease: A double-blind randomized clinical trial","volume":"82","author":"Stoller","year":"1988","journal-title":"Br J Dis Chest"},{"issue":"1","key":"10.1016\/j.slasd.2025.100260_bib0037","first-page":"23","article-title":"Timolol maleate a gold standard drug in glaucoma used as ocular films and inserts: an overview","volume":"3","author":"Rathore","year":"2010","journal-title":"Int J Pharm Sci Rev Res"},{"issue":"2","key":"10.1016\/j.slasd.2025.100260_bib0038","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0014-2999(02)01422-X","article-title":"Orlistat: its current status as an anti-obesity drug","volume":"440","author":"Ballinger","year":"2002","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.slasd.2025.100260_bib0039","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1093\/jac\/dkw033","article-title":"Orlistat: weight lost at cost of HIV rebound","volume":"71","author":"Gervasoni","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.slasd.2025.100260_bib0040","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1089\/aid.2012.0017","article-title":"Loss of control of HIV viremia associated with the fat malabsorption drug orlistat","volume":"28","author":"Kent","year":"2012","journal-title":"AIDS Res Hum Retrovir"}],"container-title":["SLAS Discovery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247255522500053X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S247255522500053X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:52:40Z","timestamp":1790283160000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S247255522500053X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":40,"alternative-id":["S247255522500053X"],"URL":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100260","relation":{},"ISSN":["2472-5552"],"issn-type":[{"value":"2472-5552","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A high-throughput approach to evaluating NCp7 RNA binding activity for HIV-1 drug discovery","name":"articletitle","label":"Article Title"},{"value":"SLAS Discovery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.slasd.2025.100260","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of Society for Laboratory Automation and Screening.","name":"copyright","label":"Copyright"}],"article-number":"100260"}}